Quantcast

Latest Lower urinary tract symptoms Stories

2009-02-27 22:32:32

Healthy men screened regularly for prostate cancer who show no symptoms should talk with doctors about a drug, new U.S. guidelines advise. The newly released joint guideline produced by the American Society of Clinical Oncology and the American Urological Association recommends that men with a prostate-specific antigen score of 3.0 or below who have no symptoms of the disease should discuss with doctors using a 5-alpha reductase inhibitor to prevent the disease. The 5-alpha reductase...

2008-12-11 06:30:00

QUEBEC CITY, Dec. 11 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported it has reached its goal of recruiting 500 patients for the safety study of the Phase 3 program in benign prostatic hyperplasia (BPH) with its flagship product candidate, cetrorelix, a novel investigational luteinizing hormone-releasing hormone (LHRH) antagonist. This safety trial, the third of three Phase 3...

2008-10-13 12:00:17

The U.S. Food and Drug Administration has approved Rapaflo (silodosin) capsules for the treatment of symptoms due to benign prostatic hyperplasia. "Benign prostatic hyperplasia (also known as an enlarged prostate gland) can seriously impact the quality of life of men as they age," said George Benson, deputy director of the FDA's division of reproductive and urological products. "This product will provide another treatment option for men suffering symptoms of an enlarged prostate." The drug...

2008-10-10 09:00:19

Watson Pharmaceuticals, a specialty pharmaceutical company, has received the FDA approval for Rapaflo, the company's new alpha blocker for the treatment of the signs and symptoms of benign prostatic hyperplasia. The approval is based on data from two Phase III, 12-week, randomized, double-blind, placebo-controlled, multi-center studies as well as a 40 week open label study. In the two Phase III studies, 923 patients (mean age 64.6 years) were randomized to receive either Rapaflo 8mg...

2008-10-01 09:00:49

AEterna Zentaris Inc. (NASDAQ: AEZS; TSX:ÃӚ“šÃƒÆ’“šÃƒ“š AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported the completion of patient recruitment for the Company's second efficacy trial of its Phase 3 program in benign prostatic hyperplasia (BPH), a non-cancerous enlargement...

2008-09-30 03:00:00

By Strief, Dawn Mielke This review of the state of the science for prostate cancer includes a description of current screening, diagnosis, and treatment options for localized prostate cancer. Educational resources appropriate for at-risk patients are outlined. - Linda H. Yoder, PhD, MBA, RN, AOCN(R), FAAN Prostate cancer is the most commonly diagnosed cancer and the second leading cause of cancer-related death among American males (Terris & Rhee, 2006). The incidence of this disease...

2008-09-19 09:00:11

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce two separate presentations of new data by independent clinical investigators involved in U.S. clinical trials of NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH). The first presentation was at the annual meeting of the Northeastern Section of the American Urological Association in Santa Ana Pueblo, NM; the second at the annual meeting of the South Central Section of the American Urological...

2008-09-12 03:00:06

By Ellsworth, Pamela Caldamone, Anthony Voiding dysfunction and urinary incontinence in children is common. Both are associated with significant effects on quality of life and comorbidities, including urinary tract infections (UTIs) and constipation. A thorough history, physical examination, and non- invasive evaluation are essential in determining the etiology. Interventions, such as behavioral therapy/biofeedback and pharmacologic therapies, are primary treatments. Prevalence rates,...

2008-09-05 15:00:31

HUNTINGTON BEACH, Calif., Sept. 5 /PRNewswire/ -- Men in the Los Angeles area who suffer from the symptoms associated with an enlarged prostate now have the option of out-patient, in-office treatment to cure the problem. Orange Coast Urology of Huntington Beach is now offering the LIFE(TM) (Laser Induced Flow Enhancement) procedure using the EVOLVE(R) Laser System in their office. The LIFE(TM) procedure is a breakthrough laser treatment for benign prostate hyperplasia (BPH) that quickly and...

2008-08-25 09:00:26

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 25, 2008) - Urodynamix Technologies Ltd. (TSX VENTURE:URO) today announced that it has received a non-refundable financial contribution from the National Research Council Canada Industrial Research Assistance Program (NRC-IRAP) to help accelerate the development and commercialization of new NIRS technology for the detection of prostate cancer during the digital rectal examination, or DRE. Urodynamix's new technology, based on near infrared...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related